12:00 AM
 | 
Jan 15, 2015
 |  BC Innovations  |  Distillery Techniques

Bio Markers

TECHNOLOGY: Low-density lipoprotein receptor (LDLR) and apolipoprotein A-V (APOA5) mutations to predict early-onset myocardial infarction (MI) risk

SNPsGenetic sequencing studies identified rare mutations in LDLR and APOA5 that could predict risk of early onset MI. Exome sequencing...

Read the full 170 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >